Syros to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Syros Pharmaceuticals (SYRS) management will participate in fireside chats at the Piper Sandler 35th Annual Healthcare Conference and the JMP Securities Hematology and Oncology Summit. The webcasts and archived recordings will be available on the Syros website.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that company management will participate in a fireside chat at two upcoming investor conferences. Management will also be available for one-on-one meetings. Details are as follows:

Piper Sandler 35th Annual Healthcare Conference
Date: Tuesday, November 28
Presentation Time: 2:00 p.m. ET
Location: The Lotte New York Palace, 455 Madison Ave, New York, NY

JMP Securities Hematology and Oncology Summit
Date: Wednesday, December 6
Presentation Time: 11:00 a.m. ET
Location: Virtual

To access the webcasts and subsequent archived recording of each event, please visit the Investors & Media section of the Syros website at www.syros.com. An archived replay of each webcast will be available for approximately 30 days following each presentation.

About Syros Pharmaceuticals

Syros is committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies. Driven by the motivation to help patients with blood disorders that have largely eluded other targeted approaches, Syros is developing tamibarotene, an oral selective RARα agonist in frontline patients with higher-risk myelodysplastic syndrome and acute myeloid leukemia with RARA gene overexpression. For more information, visit www.syros.com and follow us on Twitter (@SyrosPharma) and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231121742692/en/

Syros Contact

Karen Hunady

Director of Corporate Communications & Investor Relations

1-857-327-7321

khunady@syros.com

Investor Contact

Hannah Deresiewicz

Stern Investor Relations, Inc.

212-362-1200

hannah.deresiewicz@sternir.com

Source: Syros Pharmaceuticals

FAQ

When will Syros Pharmaceuticals participate in the Piper Sandler 35th Annual Healthcare Conference?

Syros Pharmaceuticals will participate on Tuesday, November 28 at 2:00 p.m. ET.

Where will the presentation take place at the Piper Sandler 35th Annual Healthcare Conference?

The presentation will be at The Lotte New York Palace, 455 Madison Ave, New York, NY.

When will Syros Pharmaceuticals participate in the JMP Securities Hematology and Oncology Summit?

Syros Pharmaceuticals will participate on Wednesday, December 6 at 11:00 a.m. ET.

Where will the presentation take place at the JMP Securities Hematology and Oncology Summit?

The presentation will be virtual.

Where can the webcasts and archived recordings be accessed?

The webcasts and archived recordings can be accessed on the Syros website at www.syros.com.

How long will the archived replay of each webcast be available?

The archived replay of each webcast will be available for approximately 30 days following each presentation.